Ignite Creation Date:
2024-10-26 @ 3:38 PM
Last Modification Date:
2024-10-26 @ 3:38 PM
Study NCT ID:
NCT06569225
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-08-21
Brief Title:
GemcitabineCisplatinNab-Paclitaxel and Rilvegostomig in Resectable iCCA
Sponsor:
Organization:
None